Stockscreener 앱 받기
2.27
0.00%
0.00
Zynex Inc 주식(ZYXI)의 최신 뉴스
Muscle Stimulation Devices Market Future Business - openPR.com
Royal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock Price - MarketBeat
Zynex stock price target lowered to $3 by RBC amid payment issues - Investing.com Nigeria
Zynex (ZYXI) Target Price Lowered by RBC Capital, Maintains Rati - GuruFocus
RBC Capital Downgrades Zynex to Sector Perform, PT to $3 from $4. - AInvest
RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating - MarketScreener
Zynex: New CEO Steven Dyson shares his vision – ICYMI - Proactive financial news
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Execs Of Device Co. Made $6M From Insider Trading, Suit Says - Law360
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Zynex Shareholder Sues Board, Execs Over Insurer’s Payment Pause - Bloomberg Law News
Zynex names Steven Dyson new CEO - ColoradoBiz
Zynex appoints Steven Dyson as CEO; founder Thomas Sandgaard moves to Chairman role to steer vision - Proactive financial news
Zynex CEO Thomas Sandgaard discusses leadership transitionICYMI - Proactive financial news
Zynex confirms continued temporary payment suspension from Tricare - Proactive financial news
Zynex Faces Continued Payment Suspension from Tricare - The Globe and Mail
Zynex Says Tricare Payment Suspension Will Continue Amid Review - MarketScreener
Zynex stock falls after Tricare extends payment suspension - Investing.com
Zynex stock falls after Tricare extends payment suspension By Investing.com - Investing.com India
Zynex, Inc. (ZYXI): Can Strategic Shifts and Liquidity Maneuvers Turn the Tide on Tricare's Stranglehold? - AInvest
Tricare Temporary Payment Suspension Update - PR Newswire
Medtech firm replacing CEO as it grapples with revenue loss, legal challenges - The Business Journals
Zynex appoints Steven Dyson as CEO, founder Thomas Sandgaard transitions to Chairman role - Proactive financial news
Zynex Appoints Steven Dyson as New CEO - TipRanks
H.C. Wainwright reiterates Buy rating on Zynex stock with $8 price target - Investing.com India
Zynex appoints Steven Dyson as new CEO effective August 18 By Investing.com - Investing.com Canada
Zynex Announces Steven Dyson as New CEO - GuruFocus
Zynex taps Steve Dyson as chief executive officer - Proactive financial news
Zynex, Inc.(NasdaqGS: ZYXI) dropped from Russell Small Cap Comp Growth Index - MarketScreener
Zynex Announces Steven Dyson as New CEO | ZYXI Stock News - GuruFocus
Small cap wrap: Medicus Pharma, Zynex, Liberty Star, First Phosphate... - Proactive Investors
Zynex secures UK patent for noninvasive sepsis monitoring device - Investing.com
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis - PR Newswire
Zynex awarded UK patent for non-invasive sepsis monitoring technology | NASDAQ:ZYXI - Proactive financial news
Zynex Receives UK Patent for Noninvasive Sepsis Monitoring Device - MarketScreener
Zynex Announces Workforce Reduction for Cost Savings - TipRanks
Zynex announces workforce reduction and provides update on Tricare payment suspension - Investing.com Canada
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET - The Globe and Mail
Two Sigma Advisers LP Sells 5,000 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Zynex, Inc.'s (NASDAQ:ZYXI) Shares Bounce 41% But Its Business Still Trails The Industry - simplywall.st
Zynex, Inc. (NASDAQ:ZYXI) Shares Sold by BNP Paribas Financial Markets - Defense World
Zynex (NASDAQ:ZYXI) Stock Price Down 3.9% – What’s Next? - Defense World
Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing - openPR.com
ZYXI LAWSUIT ALERT: The Gross Law Firm Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - cnhinews.com
Zynex submits NiCO pulse oximeter technology for FDA clearanceICYMI - Proactive financial news
Here’s Why Zynex (ZYXI) Fell in Q1 - Insider Monkey
Zynex submits FDA application for NiCO, a breakthrough non-invasive co-oximeter - Proactive financial news
Zynex, Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewswire Inc.
ZYXI Deadline: ZYXI Investors with Losses in Excess of $100K Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit - marketscreener.com
May 19, 2025 Deadline: Join Class Action Lawsuit Against Zynex, Inc. (ZYXI)Contact Levi & Korsinsky - ACCESS Newswire
ZYXI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages - GlobeNewswire
ZYXI Investors Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
ZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TradingView
ZYXI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Zynex, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 19 Deadline in Securities Class Action – ZYXI - TradingView
Securities Lawsuit Alert: Zynex, Inc. (ZYXI)Contact Levi & Korsinsky Before May 19, 2025 - ACCESS Newswire
Investors who lost money on Zynex, Inc.(ZYXI) should contact The Gross Law Firm about pending Class ActionZYXI - GuruFocus
ZYXI DEADLINE ALERT: Zynex (ZYXI) Investors Alerted to - GlobeNewswire
May 19, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ZYXI - Eagle-Tribune
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex - Business Wire
1.50%
1.89%
자본화:
|
볼륨(24시간):